Family physician visits and early recognition of melanoma

Canadian Journal of Public Health

Volumn 96, Issue 2, 2005, Pages 136-139

  Di Quinzio, Melanie L ^a   Dewar, Ron A ^b   Burge, Frederick I ^a   Veugelers, Paul J ^a,c  

^a DALHOUSIE UNIVERSITY   (Canada)

^b Cancer Care Nova Scotia   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Melanoma; Neoplasms; Prevention and control; Primary health care; Public health

Indexed keywords

ADULT; AGED; AMBULATORY CARE; ARTICLE; AWARENESS; CANADA; CANCER GROWTH; CONFIDENCE INTERVAL; CONSULTATION; CONTROLLED STUDY; DATA BASE; EARLY DIAGNOSIS; FEMALE; GENERAL PRACTITIONER; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIMARY MEDICAL CARE; TUMOR VOLUME;

EID: 17244368469     PISSN: 00084263     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03403677     Document Type: Article

References (30)

1. Weinstock M. Early detection of melanoma. JAMA 2000;284(7):886-89.
2. Johnson T, Dolan O, Hamilton T, Lu M, Swanson N, Lowe L. Clinical and histologic trends of melanoma. J A Acad Dermatol 1998;38(5):681-86.
3. Rigel D, Friedman R, Kopf A. The incidence of malignant melanoma in the United States: Issues as we approach the 21st century. J Am Acad Dermatol 1996;34(5):839-47.
4. Jerant A, Johnson J, Sheridan C, Caffrey T. Early detection and treatment of skin cancer. Am Fam Phys 2000;62(2):357-68.
5. Desmond R, Soon SJ. Epidemiology of malignant melanoma. Surg Clin N Am 2003;83(1): 1-29.
6. American Cancer Society. Cancer Facts & Figures 2003. Atlanta, GA, 2003;4.
7. National Cancer Institute of Canada. Canadian Cancer Statistics 2003. Toronto, ON, 2003.
8. MacKie R. Risk factors for the development of primary cutaneous malignant melanoma. Derm Clin 2002;20(4):597-600.
9. Armstrong B, English D. Cutaneous malignant melanoma. In: Schottenfeld D, Fraumeni J (Eds.), Cancer Epidemiology and Prevention 2nd ed. New York: Oxford University Press, 1996;1282-312.
10. Elwood J, Gallagher R, Hill G, Spinelli J, Pearson J, Threlfall W. Pigmentation and skin reaction to sun as risk factors for cutaneous melanoma: Western Canada Melanoma Study. BMJ 1984;288:99-102.
11. Goldstein B, Goldstein A. Diagnosis and management of malignant melanoma. Am Fam Phys 2001;63(7):1359-68.
12. DiFronzo L, Wanek L, Morton D. Earlier diagnosis of second primary melanoma confirms the benefits of patient education and routing post-operative follow-up. Cancer 2001;91:1520-24.
13. Hall H, Miller D, Rogers J, Brewerse B. Update on the incidence and mortality from melanoma in the United States. J Am Acad Dermatol 1999;40(1):35-42.
14. Roetzheim R, Pal N, Van Durme D, Wathington D, Ferrante J, Gonzalez E, et al. Increasing supplies of dermatologists and family physicians are associated with earlier stage of melanoma detection. J Am Acad Dermatol 2000;43(2):211-18.
15. The Canadian Task Force on the Periodic Health Examinations. The Canadian Guide to Clinical Preventive Health Care. Ottawa: Minister of Supply and Services Canada, 1994.
16. Geller A. Screening for melanoma. Derm Clin 2002;20(4):629-40.
17. Epstein D, Lange J, Gruber S, Mofid M, Koch S. Is physician detection associated with thinner melanomas? JAMA 1999;281:640-43.
18. Van Durme D, Ferrante J, Pal N, Wathington D, Roetzheim R, Gonzalez E. Demographic predictors of melanoma stage at diagnosis. Arch Fam Med 2000;9:606-11.
19. Weiss L, Blustein J. Faithful patients: The effect of long-term physician-patient relationships on the costs and use of health care by older Americans. Am J Public Health 1996;86(12):1742-47.
20. Ettner S. The relationship between continuity of care and the health behaviors of patients. Does having a usual physician make a difference? Med Care 1999;37(6):547-55.
21. Krige J, Isaacs S, Hudson A, King H, Strover R, Johnson C. Delay in the diagnosis of cutaneous malignant melanoma. Cancer 1991;68:2064-68.
22. Brady M, Oliveria S, Christos P, Berwick M, Coit D, Katz J, et al. Patterns of detection in patients with cutaneous melanoma. Cancer 2000;89:342-47.
23. Richard M, Grob J, Avril M, Delanunay M, Gouvernet J, Wolkenstein P, et al. Delays in diagnosis and melanoma prognosis (II): The role of doctors. Int J Cancer 2000;89:280-85.
24. Temoshok L, Diclemente R, Sweet D, Blois M, Sagebiel R. Factors related to patient delay in seeking medical attention for cutaneous malignant melanoma. Cancer 1984;54:3048-53.
25. Veugelers PJ, Yip AM, Kephart G. Proximal and contextual socioeconomic determinants of mortality: Multilevel approaches in a setting with universal health care coverage. Am J Epidemiol 2001;154:725-32.
26. Argenziano G, Fabbrocini G, Carli P, De Giorgi V, Delfino M. Epiluminescence microscopy: Criteria of cutaneous melanoma progression. J Am Acad Dermatol 1997;37(1):68-74.
27. Slingluff Jr. C, Vollmer R, Reintgen D, Seigler H. Lethal "thin" malignant melanoma. Ann Surg 1988;208(2):150-61.
28. Fitzgerald A, Dewar R, Veugelers P. Diet quality and cancer incidence in Nova Scotia, Canada. Nutrition and Cancer 2002;43(2):127-32.
29. Veugelers PJ, Yip AM, Elliott D. Geographic variation in health services use in Nova Scotia. Chron Dis Can 2003;23:100-10.
30. Tsao H, Rogers GS, Sober AJ. An estimate of the annual direct cost of treating cutaneous melanoma. J Am Acad Dermatol 1998;38:669-80.